RAF Inhibitors

被引：0
|
作者：
Di Nicolantonio, F. [1 ]
机构：
[1] Univ Turin, Inst Canc Res & Treatment, Sch Med, Turin, Italy
来源：
EUROPEAN JOURNAL OF CANCER | 2011年 / 47卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：S68 / S68
页数：1
相关论文
共 50 条
  • [41] RAF inhibitors prime wild-type RAF to activate the MAPK pathway and enhance growth
    Hatzivassiliou, Georgia
    Song, Kyung
    Yen, Lvana
    Brandhuber, Barbara J.
    Anderson, Daniel J.
    Alvarado, Ryan
    Ludlam, Mary Jc
    Stokoe, David
    Gloor, Susan L.
    Vigers, Guy
    Morales, Tony
    Aliagas, Ignacio
    Liu, Bonnie
    Sideris, Steve
    Hoeflich, Klaus
    Jaiswal, Bijay S.
    Seshagiri, Sonnasekar
    Koeppen, Hartmut
    Belvin, Marcia
    Friedman, Lori S.
    Malek, Shiva
    CANCER RESEARCH, 2010, 70
  • [42] MEK and RAF inhibitors for BRAF-mutated cancers
    Belden, Sarah
    Flaherty, Keith T.
    EXPERT REVIEWS IN MOLECULAR MEDICINE, 2012, 14 : e17
  • [43] B-Raf and the inhibitors: from bench to bedside
    Tiangui Huang
    Michael Karsy
    Jian Zhuge
    Minghao Zhong
    Delong Liu
    Journal of Hematology & Oncology, 6
  • [44] Pharmacophore identification of Raf-1 kinase inhibitors
    Zhu, Tian
    Jiao, Yu
    Chen, Ya-Dong
    Wang, Xuan
    Li, Hui-Fang
    Zhang, Lu-Yong
    Lu, Tao
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2008, 18 (07) : 2346 - 2350
  • [45] RAF inhibitors that evade paradoxical MAPK pathway activation
    Chao Zhang
    Wayne Spevak
    Ying Zhang
    Elizabeth A. Burton
    Yan Ma
    Gaston Habets
    Jiazhong Zhang
    Jack Lin
    Todd Ewing
    Bernice Matusow
    Garson Tsang
    Adhirai Marimuthu
    Hanna Cho
    Guoxian Wu
    Weiru Wang
    Daniel Fong
    Hoa Nguyen
    Songyuan Shi
    Patrick Womack
    Marika Nespi
    Rafe Shellooe
    Heidi Carias
    Ben Powell
    Emily Light
    Laura Sanftner
    Jason Walters
    James Tsai
    Brian L. West
    Gary Visor
    Hamid Rezaei
    Paul S. Lin
    Keith Nolop
    Prabha N. Ibrahim
    Peter Hirth
    Gideon Bollag
    Nature, 2015, 526 : 583 - 586
  • [46] B-Raf kinase inhibitors for cancer treatment
    Li, Nanxin
    Batt, David
    Warmuth, Markus
    CURRENT OPINION IN INVESTIGATIONAL DRUGS, 2007, 8 (06) : 452 - 456
  • [47] Raf Inhibitors as Therapeutic Agents Against Neurodegenerative Diseases
    Burgess, Sarah
    Echeverria, Valentina
    CNS & NEUROLOGICAL DISORDERS-DRUG TARGETS, 2010, 9 (01) : 120 - 127
  • [48] Development of selective B-RAF kinase inhibitors
    Jones, John H.
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2011, 241
  • [49] An overview of RAF kinases and their inhibitors (2019-2023)
    Hashem, Omar
    Shahin, Afnan, I
    Al Hindawi, Manar A.
    Fageeri, Mohamed F.
    Al-Sbbagh, Saif A.
    Tarazi, Hamadeh
    El-Gamal, Mohammed, I
    EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2024, 275
  • [50] Design and synthesis of isoquinolines and benzimidazoles as RAF kinase inhibitors
    Buchstaller, Hans-Peter
    Burgdorf, Lars
    Finsinger, Dirk
    Stieber, Frank
    Sirrenberg, Christian
    Amendt, Christiane
    Grell, Matthias
    Zenke, Frank
    Krier, Mireille
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2011, 21 (08) : 2264 - 2269
12345